No Data
No Data
Express News | Rein Therapeutics To Present New Data On Caveolin Scaffolding Peptides In IPF And Normal Lung Samples At ATS 2025
Rein Therapeutics Announces Abstract Accepted for Presentation at the American Thoracic Society 2025 International Conference
Rein Therapeutics Awarded to Patents Related to LTI-03
Express News | Rein Therapeutics Granted Two Patents Covering the Novel Formulation and Administration Methods of Dry Powder Lti-03 for the Treatment of Respiratory Diseases
Rein Therapeutics Granted Two Patents Covering the Novel Formulation and Administration Methods of Dry Powder LTI-03 for the Treatment of Respiratory Diseases
Rein Therapeutics' LTI-2355 Peptide Shows Therapuetic Potential in Study